Condition: Prostate Cancer · Sponsor: Tyler J Curiel
The goal of this clinical trial is to learn about the tolerability of telmisartan in patients with prostate cancer, but evidence for treatment efficacy will also be gathered.
This description comes directly from the study's public registry record.
Kayla Fay · 603-650-5000 · kayla.a.fay@hitchcock.org
Always discuss trial participation with your own doctor first.
| Dartmouth Health | Lebanon, New Hampshire, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06168487